The incidence of autoimmune diseases is increasing. Antinuclear antibody (ANA) testing is a
critical tool for their diagnosis. However, ANA prevalence in healthy persons has increased …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with highly
variable clinical and immunological manifestations. In the classification of patients with this …

The indirect immunofluorescence assay (IIFA) on HEp-2 cells is widely used for detection of
antinuclear antibodies (ANA). The dichotomous outcome, negative or positive, is integrated …

The second meeting for the International Consensus on Antinuclear antibody (ANA) Pattern
(ICAP) was held on 22 September 2015, one day prior to the opening of the 12th Dresden …

The discovery and initial characterization 20 years ago of antinuclear autoantibodies (ANAs)
presenting a dense fine speckled (DFS) nuclear pattern with strong staining of mitotic …

Antinuclear antibodies (ANAs) are a spectrum of autoantibodies targeted to various nuclear
and cytoplasmic components of the cells. They are very useful as serological markers for …

Introduction: Anti-DFS70 antibodies and their clinical associations remain an immunological
paradox. Unlike other antinuclear antibodies (ANA), there is a growing body of evidence that …

Sažetak Antinuclear antibodies (ANA) represent a family of autoantibodies targeting
ubiquitous cellular constituents and are a hallmark of systemic inflammatory autoimmune …

Background Patients suffering from neurological symptoms after COVID-19 vaccination (post-
COVID-19 vaccination syndrome (PCVS)) have imposed an increasing challenge on …

Abstract Choosing Wisely®: Next Steps in Improving Healthcare Value is an initiative of the
American Board of Internal Medicine (ABIM) Foundation. The driving forces for the Choosing …